insulin aspart
insulin aspart is listed in the FDA National Drug Code directory with 36 NDC codes, marketed under brand names including Insulin Aspart Protamine and Insulin Aspart Mix 70/30, NovoLog Mix 70/30, NOVOLOG. Available dosage forms: injection, suspension, injection, solution, powder.
Drug details
- Generic Name
- insulin aspart
- Brand Names
- Insulin Aspart Protamine and Insulin Aspart Mix 70/30, NovoLog Mix 70/30, NOVOLOG, Insulin Aspart, Fiasp, NOVOLOG MIX 70/30, .Insulin Aspart Protamine and Insulin Aspart
- Application Number
- BLA021172
- Sponsor
- REMEDYREPACK INC.
- NDC Codes
- 36
- Dosage Forms
- INJECTION, SUSPENSION, INJECTION, SOLUTION, POWDER
- Routes
- SUBCUTANEOUS, INTRAVENOUS
- Active Ingredients
- INSULIN ASPART
Indications and Usage
1 INDICATIONS AND USAGE NOVOLOG MIX 70/30 is a mixture of insulin aspart protamine and insulin aspart indicated to improve glycemic control in adult patients with diabetes mellitus. Limitations of Use: NOVOLOG MIX 70/30 is not recommended for the treatment of diabetic ketoacidosis. The proportions of rapid-acting and long-acting insulins in NOVOLOG MIX 70/30 are fixed and do not allow for basal versus prandial dose adjustments. NOVOLOG MIX 70/30 is a mixture of insulin aspart protamine, an intermediate-acting human insulin analog, and insulin aspart, a rapid-acting human insulin analog, indicated to improve glycemic control in adult patients with diabetes mellitus. Limitations of Use: Not recommended for the treatment of diabetic ketoacidosis. The proportions of rapid-acting and long-acting insulins are fixed and do not allow for basal versus prandial dose adjustments (1) .